Skip to main content
Caris Life SciencesLinkedIn

Caris platform offers comprehensive tumor profiling using tissue and liquid biopsy for treatment decisions.

Source

LinkedInAug 11, 2026
likes
74
comments
0

Post

Why choose between tissue and liquid biopsy when both could provide critical insights? The MI Cancer Seek® platform delivers comprehensive tumor profiling, including key mutations, fusions, protein expression, TMB, GPSai® and companion diagnostic indications. Caris Assure® adds a rapid, real-time view of circulating tumor DNA and tumor evolution while distinguishing tumor-derived alterations from clonal hematopoiesis. Concurrent testing provides a more complete molecular picture to help guide treatment decisions from the start. Learn more: https://ow.ly/QB4B50ZjHOo

linkedin.com/posts/caris-life-sciences_why-choose-between-tissue-and-...Read the full source

Extracted by Autobound

From the Signal API record
Signal
LinkedIn

What this signalsCompany posts often show what the team is pushing right now.

The full record

From the Signal API record

Topics and mentions

Tags

  • Medical Research
  • Healthcare Technology
  • Product Development
  • Data Science

Initiatives

  • comprehensive tumor profiling for treatment guidance

Technologies named

  • MI Cancer Seek®
  • Caris Assure®

Extraction

Detected
Aug 13, 2026
signal_type
linkedin-post-company
signal_subtype
linkedinPost

Use this data

Get every LinkedIn signal for Caris Life Sciences and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Caris Life Sciences this week?”

  2. Send it to your own tools

    The Signal API returns LinkedIn signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full linkedin-post-company record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/238f9454-7dcd-4492-bfe4-29c9a4436f6c returns this record as JSON. POST /v1/companies/enrich returns every signal for carislifesciences.com.

{
  "signal_id": "238f9454-7dcd-4492-bfe4-29c9a4436f6c",
  "signal_type": "linkedin-post-company",
  "signal_subtype": "linkedinPost",
  "detected_at": "2026-08-13T09:52:42.913+00:00",
  "company": {
    "name": "Caris Life Sciences",
    "domain": "carislifesciences.com"
  },
  "data": {
    "tags": [
      "Medical Research",
      "Healthcare Technology",
      "Product Development",
      "Data Science"
    ],
    "summary": "Caris platform offers comprehensive tumor profiling using tissue and liquid biopsy for treatment decisions.",
    "post_url": "https://www.linkedin.com/posts/caris-life-sciences_why-choose-between-tissue-and-liquid-biopsy-activity-7492980723889516544-M67e",
    "num_likes": 74,
    "post_text": "Why choose between tissue and liquid biopsy when both could provide critical insights? \n\nThe MI Cancer Seek® platform delivers comprehensive tumor profiling, including key mutations, fusions, protein expression, TMB, GPSai® and companion diagnostic indications. Caris Assure® adds a rapid, real-time view of circulating tumor DNA and tumor evolution while distinguishing tumor-derived alterations from clonal hematopoiesis. \n\nConcurrent testing provides a more complete molecular picture to help guide treatment decisions from the start. \n\nLearn more: https://ow.ly/QB4B50ZjHOo",
    "initiatives": [
      {
        "topic": "comprehensive tumor profiling for treatment guidance",
        "urgency": 0.7
      }
    ],
    "posted_date": "2026-08-11T16:30:17.425Z",
    "num_comments": 0,
    "technologies_mentioned": [
      {
        "name": "MI Cancer Seek®",
        "status": "using"
      },
      {
        "name": "Caris Assure®",
        "status": "using"
      }
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.